Financhill
Sell
27

LTRN Quote, Financials, Valuation and Earnings

Last price:
$3.88
Seasonality move :
3.04%
Day range:
$3.62 - $3.90
52-week range:
$2.55 - $6.12
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
4.37x
Volume:
70.6K
Avg. volume:
97.3K
1-year change:
7.14%
Market cap:
$41.9M
Revenue:
--
EPS (TTM):
-$1.75

Earnings Data

Next earnings date for LTRN
Mar 26
2026
Most recent earnings per share
-$0.39
Beat by $0.08
(Nov 13/2025)
Consensus Estimate
-$0.47
(Nov 13/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

LTRN Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/26/2026 Q4 -- -- -- -$0.46 --
11/13/2025 Q3 -- -- -$0.39 -$0.47 $0.08
08/13/2025 Q2 -- -- -$0.40 -$0.49 $0.08
05/08/2025 Q1 -- -- -$0.42 -$0.49 $0.07
03/27/2025 Q4 -- -- -$0.54 -$0.51 -$0.03
11/07/2024 Q3 -- -- -$0.42 -- --
08/08/2024 Q2 -- -- -$0.46 -- --
05/09/2024 Q1 -- -- -$0.51 -$0.43 -$0.08
03/18/2024 Q4 -- -- -$0.39 -$0.32 -$0.07
11/08/2023 Q3 -- -- -$0.29 -$0.48 $0.19
08/09/2023 Q2 -- -- -$0.44 -$0.45 $0.01
05/09/2023 Q1 -- -- -$0.36 -$0.48 $0.12
03/20/2023 Q4 -- -- -$0.31 -- --
11/07/2022 Q3 -- -- -$0.21 -- --
08/08/2022 Q2 -- -- -$0.41 -- --
05/03/2022 Q1 -- -- -$0.38 -$0.29 -$0.09
03/10/2022 Q4 -- -- -$0.32 -$0.41 $0.09
11/01/2021 Q3 -- -- -$0.36 -$0.25 -$0.12
07/29/2021 Q2 -- -- -$0.21 -$0.26 $0.05
05/03/2021 Q1 -- -- -$0.24 -$0.27 $0.03
03/10/2021 Q4 -- -- -$0.55 -$0.46 -$0.10
10/29/2020 Q3 -- -- -$0.27 -$0.36 $0.09
07/30/2020 Q2 -- -- -$0.31 -$0.37 $0.06
03/31/2020 Q1 -- -- -$0.08 -- --
12/31/2019 Q4 -- -- -$0.11 -- --
09/30/2019 Q3 -- -- -$0.11 -- --
06/30/2019 Q2 -- -- -$0.10 -- --
03/31/2019 Q1 -- -- -$0.07 -- --

Lantern Pharma, Inc. Earnings Questions

  • How Much did Lantern Pharma, Inc. Generate in Revenue Last Quarter?

    Lantern Pharma, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did Lantern Pharma, Inc. Beat Earnings Last Quarter?

    Lantern Pharma, Inc. announced earnings per share of -$0.39 which represents a beat of analyst forecast a -$0.47 per share.

  • Is Lantern Pharma, Inc. Profitable?

    Lantern Pharma, Inc. reported -$4.1K that represents -$0.00 per share over the last quarter.

  • What is the Analyst Consensus for Lantern Pharma, Inc. EPS Next Year?

    Lantern Pharma, Inc.'s earnings are forecast to decrease from -$1.93 per share to -$1.92 per share next year representing a decrease of -13.51%.

  • When is Lantern Pharma, Inc.'s Earnings Date?

    Lantern Pharma, Inc.'s next earnings date is March 26, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Will Robinhood Win AI Investing?
Will Robinhood Win AI Investing?

Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
81
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Buy
56
SMX alert for Dec 8

SMX (Security Matters) Plc [SMX] is down 59.64% over the past day.

Buy
62
PRAX alert for Dec 8

Praxis Precision Medicines, Inc. [PRAX] is up 9.18% over the past day.

Sell
13
PSN alert for Dec 8

Parsons Corp. [PSN] is down 5.19% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock